子宮肌瘤治療藥物市場 - 按藥物類別（黃體素釋放子宮內避孕器、避孕藥、促性腺激素釋放激素拮抗劑）、類型（黏膜下、壁內）、配銷通路、全球預測，2023-2032 年

從 2023 年到 2032 年，子宮肌瘤治療藥物市場規模預計將以 10% 的年複合成長率大幅成長。全球子宮肌瘤盛行率不斷上升，引發了對有效藥物干涉措施的更高需求。

最近，人們越來越重視開發和提供先進的藥物療法，以有效控制症狀並縮小腫瘤大小。根據婦女健康辦公室的數據，20% 至 80% 的女性在 50 歲時會罹患肌瘤。因此，更加關注解決受影響個體的治療需求已經為廣泛的研發工作讓路。此外，患者和醫療保健專業人員對可用治療方案的認知不斷提高也提振了產品需求。

子宮肌瘤治療藥物產業分為藥物類別、類型、配銷通路和區域。

按藥物類別分類，促性腺激素釋放激素拮抗劑細分市場的市場佔有率預計在2023 年至2032 年間將出現大幅成長。這可歸因於促性腺激素釋放激素(GnRH) 拮抗劑作為可行的非侵入性治療選擇的廣泛使用。 GnRH 拮抗劑能夠快速緩解症狀並減輕月經出血量，因此越來越受到重視。有利的安全性和有限的副作用等好處將進一步促進該細分市場的成長。

醫院配銷通路​​領域的子宮肌瘤治療藥物行業在2022 年產生了可觀的收入，預計到2032 年將強勁擴張。這種成長可歸因於醫院強大的基礎設施和綜合的患者護理方法，以確保有效的治療和改善患者的狀況結果。隨著人們對微創手術的日益青睞，醫院也擴大採用先進的藥物解決方案來有效管理肌瘤。

從區域來看，由於醫療基礎設施發展的激增、人們對子宮肌瘤的認知不斷提高以及健康狀況的患病率不斷上升，預計到2032 年，亞太地區子宮肌瘤治療藥物行業將出現顯著成長。微創手術的日益普及導致了針對該地區特定需求量身定做的新型藥物解決方案的推出。

此外，旨在提高功效和盡量減少不利影響的持續研發活動將增強區域市場前景。舉個例子，2022年7月，日本Kissei製藥有限公司開始了GNRH拮抗劑林札戈利（KLH-2109）治療子宮肌瘤的日本III期臨床研究。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：子宮肌瘤治療藥物市場洞察

• 產業格局
• 產業影響力
  • 成長動力
    • 子宮肌瘤盛行率增加
    • 女性子宮肌瘤新藥的開發
    • 人們對子宮肌瘤的認知不斷提高
  • 產業陷阱與挑戰
    • 與子宮肌瘤治療藥物相關的不良反應
• 成長潛力分析
• COVID-19 影響分析
• 監管環境
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 競爭定位矩陣
• 戰略儀錶板

第 5 章：子宮肌瘤治療藥物市場估計與預測：按藥物類別

• 主要動向：依藥物類別
• 孕激素緩釋子宮內避孕器 (IUD) 和避孕藥具
• 促性腺激素釋放激素 (GnRH) 拮抗劑
• 促性腺激素釋放激素 (GnRH) 激動劑
• 非荷爾蒙藥物
• 其他藥物類別

第 6 章：子宮肌瘤治療藥物市場估計與預測：按類型

• 主要動向：依類型
• 黏膜下肌瘤
• 壁內肌瘤
• 漿膜下肌瘤
• 帶蒂肌瘤

第 7 章：子宮肌瘤治療藥物市場估計與預測：按配銷通路

• 主要動向：按配銷通路
• 零售藥局
• 醫院藥房
• 其他分銷管道

第 8 章：子宮肌瘤治療藥物市場估計與預測：按地區

• 主要動向：按地區
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 瑞士
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第 9 章：公司簡介

• Pfizer, Inc.
• Abbvie, Inc.
• AstraZeneca plc
• Bayer AG
• Myovant Sciences Gmbh
• Ferring B.V.
• Amring Pharmaceuticals Inc.
• Theramex
• Watson Pharma, Inc.

Uterine Fibroid Treatment Drugs Market size is set to witness substantial growth at 10% CAGR from 2023-2032. The escalating prevalence of uterine fibroids worldwide is triggering the heightened need for efficacious pharmaceutical interventions.

Of late, there has been growing emphasis on developing and providing advanced drug therapies to effectively manage symptoms and reduce tumor size. According to the Office on Women's Health, between 20% and 80% of women develop fibroids by the age of 50 years. Thus, the higher focus on addressing the therapeutic needs of affected individuals has made way for extensive R&D efforts. Moreover, the surging awareness among patients and healthcare professionals about available treatment options is also bolstering the product demand.

The uterine fibroid treatment drugs industry is segmented into drug class, type, distribution channel, and region.

By drug class, the market share from the gonadotropin-releasing hormone antagonist segment is set to witness considerable growth between 2023 and 2032. This can be attributed to the expanding utilization of gonadotropin-releasing hormone (GnRH) antagonists as viable non-invasive treatment options. With their ability to provide rapid symptomatic relief and alleviate heavy menstrual bleeding, GnRH antagonists are gaining significant prominence. Benefits, such as favorable safety profile and limited side effects will further contribute to the segment growth.

Uterine fibroid treatment drugs industry from the hospital distribution channel segment generated substantial revenue in 2022 and is expected to foresee robust expansion through 2032. The growth can be attributed to the robust infrastructure and integrated approach to patient care in hospitals for ensuring effective treatment and improved patient outcomes. With the growing preference for minimally invasive procedures, hospitals are also increasingly adopting advanced pharmaceutical solutions for effective fibroid management.

Regionally, the Asia Pacific uterine fibroid treatment drugs industry is projected to depict notable growth rate through 2032 fueled by the upsurge in healthcare infrastructure development, increasing awareness about uterine fibroids, and the rising prevalence of the health condition. The growing adoption of minimally invasive procedures has led to the introduction of novel pharmaceutical solutions tailored for specific needs in the region.

Moreover, the ongoing research and development activities aimed at enhancing the efficacy and minimizing adverse effects will augment the regional market outlook. To cite an instance, in July 2022, Japan-based Kissei Pharmaceutical Co., Ltd. began a Japanese Phase III clinical study for the GNRH antagonist linzagolix (KLH-2109) in uterine fibroids.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug class trends
  • 2.1.4 Type trends
  • 2.1.5 Distribution channel trends

Chapter 3 Uterine Fibroid Treatment Drugs Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of uterine fibroid
    • 3.2.1.2 Development of new drugs for women with uterine fibroids
    • 3.2.1.3 Growing awareness about uterine fibroids
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Adverse effects associated with uterine fibroid treatment drugs
• 3.3 Growth potential analysis
  • 3.3.1 By drug class
  • 3.3.2 By type
  • 3.3.3 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Drug Class (USD Million)

• 5.1 Key trends, by drug class
• 5.2 Progestin-releasing intrauterine device (IUD) & contraceptives
• 5.3 Gonadotropin-releasing hormone (GnRH) antagonists
• 5.4 Gonadotropin-releasing hormone (GnRH) agonists
• 5.5 Non-hormonal medications
• 5.6 Other drug classes

Chapter 6 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Type (USD Million)

• 6.1 Key trends, by type
• 6.2 Submucosal fibroids
• 6.3 Intramural fibroids
• 6.4 Subserosal fibroids
• 6.5 Pedunculated fibroids

Chapter 7 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Distribution Channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Retail pharmacies
• 7.3 Hospital pharmacies
• 7.4 Other distribution channels

Chapter 8 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Switzerland
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Pfizer, Inc.
• 9.2 Abbvie, Inc.
• 9.3 AstraZeneca plc
• 9.4 Bayer AG
• 9.5 Myovant Sciences Gmbh
• 9.6 Ferring B.V.
• 9.7 Amring Pharmaceuticals Inc.
• 9.8 Theramex
• 9.9 Watson Pharma, Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug class (2022)
• TABLE 3 Market revenue, by type (2022)
• TABLE 4 Market revenue, by distribution channel (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global uterine fibroid treatment drugs market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global uterine fibroid treatment drugs market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 9 Global uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 10 Global uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 11 Global uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 12 Global uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 13 Global uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Competitive benchmarking of major market players
• TABLE 16 Competitive positioning matrix: Classification criteria
• TABLE 17 Strategic outlook matrix: Classification criteria
• TABLE 18 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2018 - 2022 (USD Million)
• TABLE 19 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2023 - 2032 (USD Million)
• TABLE 20 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 21 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 22 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 23 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 24 Non-hormonal medications market size, by region, 2018 - 2022 (USD Million)
• TABLE 25 Non-hormonal medications market size, by region, 2023 - 2032 (USD Million)
• TABLE 26 Other drug classes market size, by region, 2018 - 2022 (USD Million)
• TABLE 27 Other drug classes market size, by region, 2023 - 2032 (USD Million)
• TABLE 28 Submucosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 29 Submucosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 30 Intramural fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 31 Intramural fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 32 Subserosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 33 Subserosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 34 Pedunculated fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 35 Pedunculated fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 36 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 37 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 38 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 39 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 40 Other distribution channels market size, by region, 2018 - 2022 (USD Million)
• TABLE 41 Other distribution channels market size, by region, 2023 - 2032 (USD Million)
• TABLE 42 North America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 43 North America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 44 North America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 45 North America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 46 North America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 47 North America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 48 North America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 49 North America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 50 U.S. uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 51 U.S. uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 52 U.S. uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 53 U.S. uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 54 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 55 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 56 Canada uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 57 Canada uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 58 Canada uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 59 Canada uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 60 Canada uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 61 Canada uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 62 Europe uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 63 Europe uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 64 Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 65 Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 66 Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 67 Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 68 Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 69 Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 70 Germany uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 71 Germany uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 72 Germany uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 73 Germany uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 74 Germany uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 75 Germany uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 76 UK uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 77 UK uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 78 UK uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 79 UK uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 80 UK uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 81 UK uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 82 France uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 83 France uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 84 France uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 85 France uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 86 France uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 87 France uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 88 Spain uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 89 Spain uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 90 Spain uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 91 Spain uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 92 Spain uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 93 Spain uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 94 Italy uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 95 Italy uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 96 Italy uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 97 Italy uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 98 Italy uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 99 Italy uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 100 Switzerland uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 101 Switzerland uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 102 Switzerland uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 103 Switzerland uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 104 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 105 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 106 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 107 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 108 Rest of Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 109 Rest of Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 110 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 111 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 112 Asia Pacific uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 113 Asia Pacific uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 114 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 115 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 116 Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 117 Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 118 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 119 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 120 China uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 121 China uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 122 China uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 123 China uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 124 China uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 125 China uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 126 Japan uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 127 Japan uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 128 Japan uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 129 Japan uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 130 Japan uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 131 Japan uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 132 India uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 133 India uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 134 India uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 135 India uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 136 India uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 137 India uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 138 Australia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 139 Australia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 140 Australia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 141 Australia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 142 Australia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 143 Australia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 144 South Korea uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 145 South Korea uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 146 South Korea uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 147 South Korea uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 148 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 149 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 150 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 151 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 152 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 153 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 154 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 155 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 156 Latin America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 157 Latin America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 158 Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 159 Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 160 Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 161 Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 162 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 163 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 164 Brazil uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 165 Brazil uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 166 Brazil uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 167 Brazil uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 168 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 169 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 170 Mexico uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 171 Mexico uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 172 Mexico uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 173 Mexico uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 174 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 175 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 176 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 177 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 178 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 179 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 180 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 181 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 182 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 183 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 184 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 185 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 186 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 187 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 188 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 189 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 190 South Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 191 South Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 192 South Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 193 South Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 194 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 195 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 196 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 197 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 198 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 199 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 200 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 201 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 203 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 204 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 205 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug class
• FIG 8 Growth potential analysis, by type
• FIG 9 Growth potential analysis, by distribution channel
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive positioning matrix, 2022
• FIG 14 Strategic dashboard, 2022